{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:36:36Z","timestamp":1775817396227,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.ejphar.2005.06.049","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T11:22:41Z","timestamp":1125055361000},"page":"223-230","source":"Crossref","is-referenced-by-count":45,"title":["Effects of benzodiazepines receptor agonists on the hypothalamic\u2013pituitary\u2013adrenocortical axis"],"prefix":"10.1016","volume":"519","author":[{"given":"Jens D.","family":"Mikkelsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"S\u00f8derman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naheed","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.06.049_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders","volume":"160","author":"Arborelius","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1568007033482841","article-title":"Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site","volume":"2","author":"Atack","year":"2003","journal-title":"Curr. Drug. Target. CNS Neurol. Disord."},{"key":"10.1016\/j.ejphar.2005.06.049_bib3","first-page":"291","article-title":"International Union of Pharmacology: XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2005.06.049_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1460-9568.2004.03167.x","article-title":"Local gamma-aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin-releasing factor neuron activity in the paraventricular nucleus of the hypothalamus","volume":"19","author":"Bartanusz","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2005.06.049_bib5","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1523\/JNEUROSCI.16-22-07151.1996","article-title":"Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus","volume":"16","author":"Boudaba","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2005.06.049_bib6","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.18-15-05938.1998","article-title":"Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits","volume":"18","author":"Bowers","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2005.06.049_bib7","first-page":"729","article-title":"Effects of peripheral benzodiazepine receptor ligands on hypothalamic\u2013pituitary\u2013adrenal axis function in the rat","volume":"253","author":"Calogero","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.06.049_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cne.903240204","article-title":"Projections of the ventral subiculum to the amygdala, septum, and hypothalamus: a PHAL anterograde tract-tracing study in the rat","volume":"324","author":"Canteras","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(03)01285-8","article-title":"Neuroendocrine pharmacology of stress","volume":"463","author":"Carrasco","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1523\/JNEUROSCI.22-03-00959.2002","article-title":"Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus","volume":"22","author":"Cole","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2005.06.049_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/(SICI)1096-9861(20000410)419:3<344::AID-CNE6>3.0.CO;2-Z","article-title":"GABA(A) receptor subunit expression within hypophysiotropic CRH neurons: a dual hybridization histochemical study","volume":"419","author":"Cullinan","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0361-9230(90)90149-T","article-title":"Brain benzodiazepine receptor-mediated effects on plasma catecholamine and corticosterone concentrations in rats","volume":"24","author":"De Boer","year":"1990","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2005.06.049_bib14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/cne.903020423","article-title":"GABA: a dominant neurotransmitter in the hypothalamus","volume":"302","author":"Decavel","year":"1990","journal-title":"J. Comp. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2005.06.049_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-3956(90)90042-O","article-title":"Neuroendocrine effects of benzodiazepines","volume":"24","author":"De Souza","year":"1990","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2005.06.049_bib15","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1210\/en.2003-0097","article-title":"Effects of long-term voluntary exercise on the mouse hypothalamic\u2013pituitary\u2013adrenocortical axis","volume":"144","author":"Droste","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2005.06.049_bib16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0306-4522(94)00433-6","article-title":"Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain","volume":"64","author":"Duncan","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2005.06.049_bib17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0306-4522(94)00402-Q","article-title":"Cellular localization and differential distribution of GABAA receptor subunit proteins and messenger RNAs within hypothalamic magnocellular neurons","volume":"64","author":"Fenelon","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2005.06.049_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/jpet.102.033886","article-title":"Molecular actions of (S)-desmethylzopiclone (SEP-174559), an anxiolytic metabolite of zopiclone","volume":"302","author":"Fleck","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.06.049_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0166-2236(96)10069-2","article-title":"Neurocircuitry of stress: central control of the hypothalamo\u2013pituitary\u2013adrenocortical axis","volume":"20","author":"Herman","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2005.06.049_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yfrne.2003.07.001","article-title":"Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo\u2013pituitary\u2013adrenocortical responsiveness","volume":"24","author":"Herman","year":"2003","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2005.06.049_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(83)90194-5","article-title":"Acute and delayed effects of picrotoxin on the adrenocorticotropic system of rats","volume":"43","author":"Ixart","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2005.06.049_bib23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-2826.2001.00712.x","article-title":"Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: effects of acute stress and 5-HT(1A) receptor activation","volume":"13","author":"Jensen","year":"2001","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10253890009001125","article-title":"Substance P is involved in terminating the hypothalamo\u2013pituitary\u2013adrenal axis response to acute stress through centrally located neurokinin-1 receptors","volume":"3","author":"Jessop","year":"2000","journal-title":"Stress"},{"key":"10.1016\/j.ejphar.2005.06.049_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0306-4530(97)00026-7","article-title":"Diazepam attenuation of restraint stress-induced corticosterone levels is enhanced by prior exposure to repeated restraint","volume":"22","author":"Kalman","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2005.06.049_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1196\/annals.1296.057","article-title":"GABAergic mechanisms constraining the activity of the hypothalamo\u2013pituitary\u2013adrenocortical axis","volume":"1018","author":"Kovacs","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2005.06.049_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000124547","article-title":"Mechanisms by which picrotoxin and a high dose of diazepam elevate plasma corticosterone level","volume":"43","author":"Lakic","year":"1986","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ejphar.2005.06.049_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cne.903420211","article-title":"Efferent connections from the lateral hypothalamic region and the lateral preoptic area to the hypothalamic paraventricular nucleus of the rat","volume":"342","author":"Larsen","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib29","first-page":"305","article-title":"Relationships between plasma corticosteroids and benzodiazepines in stress","volume":"211","author":"Le Fur","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.06.049_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2005.06.049_bib31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0028-3908(88)90098-6","article-title":"A comparison of the effects of buspirone and diazepam on plasma corticosterone levels in rat","volume":"27","author":"Matheson","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2005.06.049_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2005.06.049_bib33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0165-0173(98)00052-6","article-title":"An update on GABAA receptors","volume":"29","author":"Mehta","year":"1999","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2005.06.049_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0361-9230(98)00121-X","article-title":"Expression of Fos in the circadian system following nonphotic stimulation","volume":"47","author":"Mikkelsen","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2005.06.049_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0306-4522(02)00147-1","article-title":"GABAergic innervation of corticotropin-releasing hormone (CRH)-secreting parvocellular neurons and its plasticity as demonstrated by quantitative immunoelectron microscopy","volume":"113","author":"Miklos","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2005.06.049_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/syn.890040304","article-title":"Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain","volume":"4","author":"Owens","year":"1989","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2005.06.049_bib51","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.ejphar.2005.06.049_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01244876","article-title":"Inhibitory effect of diazepam on the activity of the hypothalamic\u2013pituitary\u2013adrenal axis in female rats","volume":"92","author":"Pivac","year":"1993","journal-title":"J. Neural Transm.: Gen. Sect."},{"key":"10.1016\/j.ejphar.2005.06.049_bib38","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1471-4159.1990.tb01237.x","article-title":"Gamma-aminobutyric acid A receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology","volume":"54","author":"Pritchett","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2005.06.049_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cne.903320109","article-title":"Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat","volume":"332","author":"Roland","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib40","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2005.06.049_bib41","first-page":"181","article-title":"Structure and pharmacology of gamma-aminobutyric acid A receptor subtypes","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2005.06.049_bib42","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0091-3057(79)90341-1","article-title":"Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors","volume":"10","author":"Squires","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2005.06.049_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0361-9230(86)90038-9","article-title":"The projections of the dorsomedial hypothalamic nucleus in the rat","volume":"16","author":"ter Horst","year":"1986","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2005.06.049_bib44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0306-4522(98)00516-8","article-title":"Temporal and regional regulation of alpha1, beta2 and beta3, but not alpha2, alpha4, alpha5, alpha6, beta1 or gamma2 GABA(A) receptor subunit messenger RNAs following one-week oral flurazepam administration","volume":"91","author":"Tietz","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2005.06.049_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/frne.1998.0172","article-title":"Forebrain pathways mediating stress-induced hormone secretion","volume":"20","author":"Van de Kar","year":"1999","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib46","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/sj.bjp.0704201","article-title":"Diazepam increases the hypothalamic\u2013pituitary\u2013adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism","volume":"133","author":"Vargas","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/cne.903530409","article-title":"Topographical organization of the rat suprachiasmatic\u2013paraventricular projection","volume":"353","author":"Vrang","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2005.06.049_bib48","first-page":"1073","article-title":"Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats","volume":"278","author":"Wilson","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.06.049_bib49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0006-8993(96)00158-8","article-title":"Prolonged induction of c-fos in neuropeptide Y- and somatostatin-immunoreactive neurons of the rat dentate gyrus after electroconvulsive stimulation","volume":"720","author":"Woldbye","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.06.049_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0168-0102(95)00988-4","article-title":"Chlordiazepoxide discriminates between the neural circuits mediating neuroendocrine responses to fear- and anxiety-producing stimuli in the rat","volume":"24","author":"Yagi","year":"1996","journal-title":"Neurosci. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905007235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905007235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T14:08:12Z","timestamp":1552918092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905007235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0014299905007235"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.06.049","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}